Inflammation-Related Signature Profile Expression as a Poor Prognosis Marker after Oxaliplatin Treatment in Colorectal Cancer

Oxaliplatin is successfully used to eradicate micro-metastasis and improve survival, whereas the benefit of adjuvant chemotherapy in the early stages of colorectal cancer remains controversial. Inflammation plays a crucial role in colorectal cancer tumorigenesis. Inflammatory mechanisms are mediated...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Bernabe, Toni, Oliver, Jordi, Sastre-Serra, Jorge, Pons, Daniel Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965239/
https://www.ncbi.nlm.nih.gov/pubmed/36835258
http://dx.doi.org/10.3390/ijms24043821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965239/
https://www.ncbi.nlm.nih.gov/pubmed/36835258
http://dx.doi.org/10.3390/ijms24043821

Ejemplares similares